At a glance
ClinicalIndex Comparison RecordN/ACompleted· 150 enrolled
Drug / intervention
levothyroxine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Five-year Follow up of a Randomized Clinical Trial of Unilateral Thyroid Lobectomy With or Without Levothyroxine Treatment Postoperatively
In Brief
An observational study evaluating levothyroxine and no levothyroxine for Recurrent Goiter. Completed, enrolled 150 participants across 1 site.
Detailed Summary
The aim of this study was to compare the prevalence of recurrent nodular goiter in the contralateral thyroid lobe among patients after unilateral thyroid lobectomy for unilateral multinodular goiter receiving versus not receiving prophylactic levothyroxine treatment postoperatively in a five-year follow-up of a randomized study
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRecurrent Goiter
CountriesPoland
Collaborators--
Timeline
N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2000
Primary CompletionDec 2003
Study CompletionDec 2008
First PostedJul 2009
TodayJul 2026
First PostedJul 17, 2009
Enrollment StartJan 1, 2000
Primary CompletionDec 1, 2003
Study CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 17.0 years ago
Interventions
levothyroxinedrug
levothyroxine 75-125 ug/day
no levothyroxinedrug
observation only without prophylactic levothyroxine